Randomized trial of PPI-amoxicillin-clarithromycin and PPI-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
Not Applicable
- Conditions
- H. pylori associated gastritis
- Registration Number
- JPRN-UMIN000010229
- Lead Sponsor
- The National Hospital Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
(1) age <20 years; (2) presence of clinically significant underlying disease (hepatic or renal disease, diabetes mellitus); (3) history of gastric surgery; (4) allergy to any of the drugs used in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method